ExLibris header image
SFX Logo
Title: Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer
Source:

Cell death & Disease [2041-4889] yr:2013


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Chang, C. "Suppression of apoptosis by pseudorabies virus Us3 protein kinase through the activation of PI3-K/Akt and NF-κB pathways." Research in Veterinary Science 95.2 (2013): 764-774. Link to SFX for this item
2. Chow, Clement Y. "Using natural variation in Drosophila to discover previously unknown endoplasmic reticulum stress genes." Proceedings of the National Academy of Sciences of the United States of America 110.22 (2013): 9013-9018. Link to Full Text for this item Link to SFX for this item
3. Galanis, E. "Phase II Trial of Intravenous Administration of Reolysin (Reovirus Serotype-3-Dearing Strain) in Patients with Metastatic Melanoma." Molecular therapy 20.10 (2011): 1375-2003. Link to Full Text for this item Link to SFX for this item
4. Song, L. "Reovirus infection of cancer cells is not due to activated Ras pathway." Cancer Gene Therapy 16.4 (2009): 382-382. Link to Full Text for this item Link to SFX for this item
5. Dionne, Kalen R. "Daxx Upregulation within the Cytoplasm of Reovirus-Infected Cells Is Mediated by Interferon and Contributes to Apoptosis." Journal of virology 87.6 (2013): 3447-3460. Link to Full Text for this item Link to SFX for this item
6. Jabre, R. "Amino acid substitutions in σ1 and μ1 outer capsid proteins are selected during mammalian reovirus adaptation to Vero cells." Virus research (2013): 188-198. Link to SFX for this item
7. Harbison, Susan T. "Genome-wide association study of sleep in Drosophila melanogaster." BMC genomics 14.1 (2013): 281-281. Link to Full Text for this item Link to SFX for this item
8. Helenius, A. "Virus entry: What has pH got to do with it?" Nature Cell Biology 15.2 (2013): 125-125. Link to SFX for this item
9. Hutter, S. "Ephemeral Sexual Dichromatism in Zebrafish (Danio rerio)." Ethology 118.12 (2012): 1208-1218. Link to Full Text for this item Link to SFX for this item
10. Alemany, R. "Viruses in cancer treatment." Clinical & translational oncology 15.3 (2012): 182-188. Link to SFX for this item
11. Comins, C. "REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer." Clinical cancer research 16.22 (2010): 5564-5572. Link to SFX for this item
12. Hingorani, P. "Systemic administration of reovirus (Reolysin) inhibits growth of human sarcoma xenografts." Cancer 117.8 (2010): 1764-1774. Link to Full Text for this item Link to SFX for this item
13. Lupfer, C. "Decreased replication of human respiratory syncytial virus treated with the proteasome inhibitor MG-132." Virus research 149.1 (2010): 36-41. Link to SFX for this item
14. Melcher, A. "Immune-mediated antitumor activity of reovirus is required for therapy and is independent of direct viral oncolysis and replication." Clinical cancer research 15.13 (2009): 4374-81. Link to SFX for this item
15. Haseley, A. "Advances in Oncolytic Virus Therapy for Glioma." Recent Patents on CNS Drug Discovery 4.1 (2009): 1-13. Link to SFX for this item
16. Kim, H. "Detection of enteroviruses and mammalian reoviruses in Korean environmental waters." Microbiology and immunology 50.10 (2006): 781-786. Link to Full Text for this item Link to SFX for this item
17. Mita, M. "Reovirus-based therapy for cancer." Expert Opinion on Biological Therapy 9.7 (2009): 817-30. Link to SFX for this item
18. Atherton, Matthew J. "Evolution of oncolytic viruses: novel strategies for cancer treatment." Immunotherapy 5.11 (2013): 1191-1206. Link to SFX for this item
19. Prestwich, RJ. "The Importance of the Immune System in Reovirus Therapy." Clinical Oncology (2008): 769-769. Link to SFX for this item
20. White, C L L. "Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial." Gene therapy 15.12 (2008): 911-20. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.